p66ShcA modulates tissue response to hindlimb ischemia
View abstract on PubMed
Summary
This summary is machine-generated.Mice lacking p66ShcA protein showed reduced tissue damage and cell death following ischemia and reperfusion. This suggests p66ShcA is key in these injury pathways, offering a potential therapeutic target.
Area Of Science
- Molecular Biology
- Cellular Biology
- Physiology
Background
- Oxidative stress is central to ischemia and ischemia/reperfusion (I/R) injury.
- p66ShcA-null mice exhibit reduced reactive oxygen species and enhanced resistance to oxidative stress-induced cell death.
Purpose Of The Study
- To investigate the role of p66ShcA in tissue damage following acute ischemia and I/R.
- To determine if p66ShcA deficiency alters susceptibility to ischemic injury.
Main Methods
- Induction of unilateral hindlimb ischemia and I/R in p66ShcA wild-type and p66ShcA-null mice.
- Assessment of blood perfusion, tissue damage (capillary density, muscle fiber necrosis), and apoptosis levels.
- In vitro analysis of isolated cells under simulated ischemic conditions.
Main Results
- p66ShcA-null mice showed significantly less capillary density decrease and muscle fiber necrosis compared to wild-type.
- Lower levels of apoptotic endothelial cells and myofibers were observed in p66ShcA-null mice post-ischemia.
- Cells from p66ShcA-null mice demonstrated resistance to apoptosis and reduced oxidative stress in vitro.
Conclusions
- p66ShcA is critical in the cell death pathways activated by acute ischemia and I/R.
- Targeting p66ShcA presents a potential therapeutic strategy for mitigating ischemic tissue damage.